Early aspirin use and the development of cardiac allograft vasculopathy in pediatric heart transplant recipients: A pediatric heart transplant society analysis.

[1]  B. Bergmark,et al.  Early aspirin use, allograft rejection, and cardiac allograft vasculopathy in heart transplantation , 2021, Clinical transplantation.

[2]  Byron H. Smith,et al.  Association of Aspirin Treatment With Cardiac Allograft Vasculopathy Progression and Adverse Outcomes After Heart Transplantation. , 2021, Journal of cardiac failure.

[3]  F. Tomai,et al.  "Cardiac allograft vasculopathy: Pathogenesis, diagnosis and therapy". , 2020, Transplantation reviews.

[4]  T. Thim,et al.  Platelet aggregation and response to aspirin therapy in cardiac allograft vasculopathy. , 2020, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[5]  S. Chih,et al.  Cardiac allograft vasculopathy: Insights on pathogenesis and therapy , 2020, Clinical transplantation.

[6]  B. Meiser,et al.  The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: Twenty-second pediatric heart transplantation report - 2019; Focus theme: Donor and recipient size match. , 2019, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[7]  D. Freimark,et al.  Early aspirin initiation following heart transplantation is associated with reduced risk of allograft vasculopathy during long‐term follow‐up , 2017, Clinical transplantation.

[8]  B. Bergmark,et al.  Early aspirin use and the development of cardiac allograft vasculopathy. , 2017, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[9]  A. Dipchand,et al.  Outcomes after percutaneous coronary artery revascularization procedures for cardiac allograft vasculopathy in pediatric heart transplant recipients: A multi-institutional study. , 2015, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[10]  Bingren Gao,et al.  Simvastatin combined with aspirin increases the survival time of heart allograft by activating CD4(+)CD25(+) Treg cells and enhancing vascular endothelial cell protection. , 2015, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.

[11]  L. Lund,et al.  The registry of the International Society for Heart and Lung Transplantation: seventeenth official pediatric heart transplantation report--2014; focus theme: retransplantation. , 2014, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[12]  A. Huisman,et al.  Distinct phenotypes of cardiac allograft vasculopathy after heart transplantation: a histopathological study. , 2014, Atherosclerosis.

[13]  B. McCrindle,et al.  Mortality and morbidity after retransplantation after primary heart transplant in childhood: an analysis from the registry of the International Society for Heart and Lung Transplantation. , 2014, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[14]  Shaun P Jackson,et al.  The role of platelets in atherothrombosis. , 2011, Hematology. American Society of Hematology. Education Program.

[15]  Clive Lewis,et al.  The International Society of Heart and Lung Transplantation Guidelines for the care of heart transplant recipients. , 2010, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[16]  R. Starling,et al.  International Society for Heart and Lung Transplantation working formulation of a standardized nomenclature for cardiac allograft vasculopathy-2010. , 2010, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[17]  C. Canter,et al.  Survival and risk factors for death after cardiac transplantation in infants. A multi-institutional study. The Pediatric Heart Transplant Study. , 1996, Circulation.

[18]  M. Ovize,et al.  Increased platelet aggregation after heart transplantation: influence of aspirin. , 1991, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[19]  Malcolm E. Turner,et al.  The Decomposition of Time-Varying Hazard into Phases, Each Incorporating a Separate Stream of Concomitant Information , 1986 .